Sofgen Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020
Revenue	423.75	403.2	403.74	331.47	324.79
Revenue Growth (YoY)	5.10%	-0.13%	21.80%	2.05%	-
Cost of Revenue	185.77	168.25	174.14	140.15	142.29
Gross Profit	237.98	234.95	229.6	191.31	182.5
Selling, General & Admin	193.35	197.52	163.67	128.26	145.07
Other Operating Expenses	-16.61	3.32	74.99	-	-
Operating Expenses	176.74	200.84	238.67	128.26	145.07
Operating Income	61.24	34.11	-9.07	63.05	37.43
Interest Expense	-40.85	-25.85	-85.58	-52.63	-41.54
Interest & Investment Income	0.66	0.1	0.06	-	-
Currency Exchange Gain (Loss)	24.37	-18.28	-5.99	-3.91	-1.83
Other Non Operating Income (Expenses)	2.88	1.88	2.18	-5.67	-4.04
EBT Excluding Unusual Items	48.3	-8.04	-98.41	0.85	-9.98
Impairment of Goodwill	-5.79	-0.84	-	-	-
Gain (Loss) on Sale of Investments	11.19	61.8	4.51	-	-
Asset Writedown	-7.73	-5.18	-	-	-
Pretax Income	45.96	47.74	-93.9	0.85	-9.98
Income Tax Expense	5.62	11.61	13.09	11.3	7.04
Earnings From Continuing Operations	40.34	36.13	-106.99	-10.45	-17.01
Minority Interest in Earnings	-	-	-	-	0.01
Net Income	40.34	36.13	-106.99	-10.45	-17.01
Net Income to Common	40.34	36.13	-106.99	-10.45	-17.01
Net Income Growth	11.67%	-	-	-	-
Shares Outstanding (Basic)	101	101	98	97	97
Shares Outstanding (Diluted)	101	101	98	97	97
Shares Change (YoY)	-0.10%	3.02%	1.04%	-	-
EPS (Basic)	0.40	0.36	-1.09	-0.11	-0.18
EPS (Diluted)	0.40	0.36	-1.09	-0.11	-0.18
EPS Growth	11.79%	-	-	-	-
Free Cash Flow	87.3	-7.61	20.02	63.22	56.48
Free Cash Flow Per Share	0.86	-0.07	0.20	0.65	0.58
Gross Margin	56.16%	58.27%	56.87%	57.72%	56.19%
Operating Margin	14.45%	8.46%	-2.25%	19.02%	11.53%
Profit Margin	9.52%	8.96%	-26.50%	-3.15%	-5.24%
Free Cash Flow Margin	20.60%	-1.89%	4.96%	19.07%	17.39%
EBITDA	69.74	41.97	1.82	74.93	48.76
EBITDA Margin	16.46%	10.41%	0.45%	22.61%	15.01%
D&A For EBITDA	8.5	7.86	10.89	11.88	11.33
EBIT	61.24	34.11	-9.07	63.05	37.43
EBIT Margin	14.45%	8.46%	-2.25%	19.02%	11.53%
Effective Tax Rate	12.22%	24.33%	-	1330.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.